Su Michael Angelo O, Doquenia Maria Leila M, Tanglao Michelle J, Rosales Raymond
Department of Internal Medicine, Metropolitan Medical Center, Manila, PHL.
Center for Neurodiagnostic and Therapeutic Services, Metropolitan Medical Center, Manila, PHL.
Cureus. 2024 Nov 21;16(11):e74131. doi: 10.7759/cureus.74131. eCollection 2024 Nov.
There are currently seven coronaviruses that can infect humans and the latest addition to these viruses is the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Infection by SARS-CoV-2 is known commonly as coronavirus disease 2019 (COVID-19). Aside from common manifestations of cough and fever, neurologic symptoms such as headache, disturbed consciousness, paresthesia, and seizures have also been seen. By identifying the incidence of peripheral immune-mediated neuropathies (PIMN), early prevention can be made.
This cross-sectional retrospective analytic study reviewed the case records of patients examined at the Center for Neurodiagnostic and Therapeutic Services (CNS) of Metropolitan Medical Center from January 2018 to December 2021.
The period incidence of Guillain-Barré Syndrome (GBS) for the years 2018-2019 and 2020-2021 were 9.21% and 24.44%, respectively. The obtained p-value was 0.0226, which was lower than the set p-value of 0.05. Therefore, the period incidence of GBS for 2020-2021 was significantly higher when compared to that of 2018-2019.
There has been an increase in cases of GBS during the COVID-19 pandemic.
目前有七种冠状病毒可感染人类，其中最新出现的是严重急性呼吸综合征冠状病毒2（SARS-CoV-2）。SARS-CoV-2感染通常被称为2019冠状病毒病（COVID-19）。除了咳嗽和发热等常见表现外，还出现了头痛、意识障碍、感觉异常和癫痫发作等神经症状。通过确定外周免疫介导性神经病（PIMN）的发病率，可以进行早期预防。
这项横断面回顾性分析研究回顾了2018年1月至2021年12月在大都会医疗中心神经诊断与治疗服务中心（CNS）接受检查的患者的病例记录。
2018 - 2019年和2020 - 2021年吉兰 - 巴雷综合征（GBS）的期间发病率分别为9.21%和24.44%。得到的p值为0.0226，低于设定的p值0.05。因此，与2018 - 2019年相比，2020 - 2021年GBS的期间发病率显著更高。
在COVID - 19大流行期间，GBS病例有所增加。
